article

Antibodies In-Depth Focus 2019

Posted: 11 September 2019 | | No comments yet

The articles in this antibodies In-Depth Focus assess the methods used to develop antibody therapeutics and the evolution of this area of medicine to identify drug targets.











To read this In-Depth Focus in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


*

*

*

*

*

*

*

*

This content is provided to you for free thanks to the kind support of our sponsors: ForteBio, GenScript, Sartorius and Sphere Fluidics

Included in this in-depth focus:

  • Evaluation of therapeutic antibody discovery technologies
    Protein therapeutics are a major class of biopharmaceuticals and monoclonal antibodies (mAbs) rule this domain. In this article, Dr Nancy Lopez-Anton outlines the key technologies employed in this important therapeutic discovery area; how they have evolved and what obstacles must be navigated to ensure future success.
  • Hitting the target – utilising recombinant antibodies for viral research
    Having worked in antibody research for over 20 years, Gary McLean has seen how the industry has progressed and understands the potential that antibodies have in the future of medicine. Nikki Withers hears how the focus has shifted from discovery to genetic sequence manipulation and how this can be applied to viral target identification and other research.

Send this to a friend